 Intra-Cellular Therapies, Inc. NASDAQ:ITCI Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Juan Sanchez - VP, Corporate Communications IR Sharon Mates - Co-Founder, Chairman, CEO President Mark Neumann - EVP Chief Commercial Officer Lawrence Hineline - SVP, Finance, CFO, Treasurer Assistant Secretary Suresh Durgam - EVP Chief Medical Officer Conference Call Participants Andrew Tsai - Jefferies Brian Abrahams - RBC Capital Markets Michael DiFiore - Evercore ISI Ami Fadia - Needham Company Ashwani Verma - UBS David Amsellem - Piper Sandler Co. Marc Goodman - SVB Securities Graig Suvannavejh - Mizuho Securities Charles Duncan - Cantor Fitzgerald Operator Good morning, ladies and gentlemen, and welcome to intracellular Therapies Third Quarter Earnings Call. At this time, all participants are in a listen-only mode. 